About Phibro Animal Health
For nearly a century, Phibro Animal Health has supplied the global livestock and poultry industries with the medicated feed additives, vaccines, and nutritional products that underpin commercial animal production. Listed on Nasdaq under the ticker PAHC, the company operates across more than 65 countries, serving integrators, veterinarians, and feed manufacturers who rely on its broad portfolio to maintain herd and flock health at scale.
Phibro's core business divides into animal health products and performance solutions. Its medicated feed additives are a cornerstone of the business, used in cattle, swine, poultry, and aquaculture to support gut health and productivity. Alongside these, the company markets vaccines for poultry and livestock, as well as mineral nutritionals and specialty ingredients that address deficiencies common in intensive production systems.
Headquartered in Teaneck, New Jersey, Phibro Animal Health traces its roots to the early twentieth century and has grown through both organic expansion and strategic acquisitions. Its manufacturing footprint spans multiple continents, giving the company the supply reliability that large-scale integrators require. The mineral and performance nutrition segment also serves companion animal and equine markets, broadening its addressable customer base beyond food-producing species.
Phibro positions itself as a value-oriented supplier, offering established, well-understood products rather than competing primarily in the novel biologics space. This focus on proven production animal solutions has allowed the company to maintain a consistent presence in markets where cost-efficiency and product familiarity are priorities for buyers. Its international sales network covers Latin America, Asia-Pacific, Europe, and the Middle East, reflecting the genuinely global nature of commercial animal agriculture.
Further information is available at pahc.com.
